✦ LIBER ✦

Predictive Factors of Response of Perianal Crohn’s Disease to Azathioprine or 6-Mercaptopurine

✍ Scribed by Thierry Lecomte; Jean-François Contou; Laurent Beaugerie; Franck Carbonnel; Stéphane Cattan; Jean-Pierre Gendre; Jacques Cosnes

Publisher: Springer
Year: 2003
Tongue: English
Weight: 246 KB
Volume: 46
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-004-6795-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with oral tacrolimus

Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae

✍ Philip W. Lowry; Amy L. Weaver; William J. Tremaine; Dr. William J. Sandborn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Our aim was to report the clinical experience with combination treatment using tacrolimus and either azathioprine (AZA) or 6-mercaptopurine (6MP) in patients with Crohn's disease (CD) perianal fistulae. The medical records of all patients with Crohn's disease perianal fistulae seen at the Mayo Clini

Efficacy of mycophenolate mofetil in pat

Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease

✍ Philip V. Hassard; Eric A. Vasiliauskas; Lori Y. Kam; Stephan R. Targan; Dr. Mar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

Predictive value of epithelial gene expr

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

✍ Ingrid Arijs; Roel Quintens; Leentje Van Lommel; Kristel Van Steen; Gert De Hert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Background: Infliximab (IFX) has become the mainstay of therapy of refractory Crohn's disease (CD). However, a subset of patients shows incomplete or no response to this agent. In this study we investigated whether we could identify a mucosal gene panel to predict (non)response to IFX in CD. Method

Closure of perianal fistula using adalim

Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies

✍ Alberto Malesci; Erika Angelucci; Cristina Bonifacio; Orsola Sociale; Paolo Omod 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

Response to faecal challenge in defuncti

Response to faecal challenge in defunctioned colonic Crohn's disease: prediction of long-term course

✍ R. Fasoli; M. G. W. Kettlewell; N. Mortensen; Dr D. P. Jewell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

Mattson B, Wallgren A. Completeness of the Swedish cancer register. Non-notified cancer cases on death certificates in 1978.

Factors predicting response to dopaminer

Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease

✍ Young H. Sung; Sun J. Chung; Sung R. Kim; Myoung C. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

## Abstract We aimed to evaluate the clinical factors predicting response to dopaminergic treatment for resting tremor in patients with Parkinson's disease (PD). Eighty‐five PD patients with prominent resting tremor, defined as tremors of score greater than 3 in at least one limb on the Unified Par